Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosisRojo Ratsimandresy, Mark S. Wilson, Hart S. Dengler et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0